Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889252 · ClinicalTrials.gov registry record · Phase 3
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
A Phase 3 study, sponsored by Vistakon Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT00889252 is a Phase 3 study that has completed, run by Vistakon Pharmaceuticals. The registered enrollment target is 250 participants.
The verdict
NCT00889252, a Phase 3 study, has completed, sponsored by Vistakon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers.
Interventions
- DEVICE contact lens with ketotifen
- DEVICE contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2009-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00889252
The ClinicalTrials.gov registry entry for NCT00889252 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vistakon Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which contact lens with ketotifen is the first listed.
NCT00889252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00889252 about?
NCT00889252 is a clinical study titled "Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers". The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers.
What is the current status of trial NCT00889252?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2009-04.
What interventions are being tested in trial NCT00889252?
The interventions under investigation include: contact lens with ketotifen (DEVICE), contact lens (DEVICE).
Who is sponsoring clinical trial NCT00889252?
This trial is sponsored by Vistakon Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.